Posts in category Business Standard
One 97 Communications reports consolidated net loss of Rs 549.60 crore in the March 2024 quarter (22-05-2024)
Sales decline 2.89% to Rs 2267.10 crore
Morning Glory Leasing Finance reports standalone nil net profit/loss in the March 2024 quarter (22-05-2024)
Sales reported at Rs 0.01 crore
Paytm slides as net loss widens to Rs 550 cr in Q4 FY24 (22-05-2024)
One 97 Communications (Paytm) declined 1.12% to Rs 347.80 after the company's consolidated net loss widened to Rs 549.6 crore in Q4 FY24 as compared with Rs 168.4 crore posted in Q4 FY23.
Indices trade with decent gains; FMCG shares advance (22-05-2024)
At 10:30 IST, the barometer index, the S&P BSE Sensex, was up 132.61 points or 0.18% to 74,086.08. The Nifty 50 index added 27.70 points or 0.12% to 22,556.75.
Greenply Inds gains as PAT soars to Rs 28 cr in Q4 FY24 (22-05-2024)
Greenply Industries advanced 2.08% to Rs 259.65 after the company's consolidated net profit surged to Rs 28.36 crore in Q4 FY24 as compared with Rs 11.07 crore in Q4 FY23.
India on the cusp of a long-awaited economic take-off: RBI Bulletin (22-05-2024)
According to Reserve Bank of Indias May Bulletin, the outlook for the global economy is turning fragile as the descent of inflation is stalling, re-igniting risks to global financial stability. Capital flows have become volatile as nervous investors turn risk averse. There is a growing optimism that India is on the cusp of a long-awaited economic take-off. Recent indicators are pointing to a quickening of the momentum of aggregate demand. Non-food spending is being pushed up by the green shoots of rural spending recovery. A modest easing of headline inflation in the reading for April 2024 confirms the expectation that an uneven and lagged pace of alignment with the target is underway.
Cipla receives USFDA approval for Lanreotide Injection (22-05-2024)
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (lanreotide) Injection and is indicated for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs).
Suzlon Group receives order for 402 MW wind energy project (22-05-2024)
These are repeat orders from the customer for the company's larger rated 3 MW, S144]140m turbines from the 3 MW product series. As part of the agreement, Suzlon will supply the wind turbines and execute the
project including foundation, erection, and commissioning. Suzlon will also undertake comprehensive operations and maintenance services post]commissioning.
Shares of JK Tyre zoom 10% amidst robust Q4 financials; profits soar (22-05-2024)
JK Tyre reported a 56 percent increase in its consolidated net profit for the fourth quarter, reaching Rs 169.33 crore, driven by sustained demand
Indian bond yields flat as traders eye next move to infuse cash in system (22-05-2024)
The government has bought back securities aggregating to only around Rs 17,900 crore ($2.15 billion), against notified quantum of Rs 1.60 trillion in May